MetaCap

Who Owns Mentari Therapeutics Stock?

NASDAQ: MTRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.70-0.545 (-3.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
1.38%
Institutional holders
20
  • Institutions 1.4%
  • Insiders 0.0%
  • Public and other 98.6%

Who owns Mentari Therapeutics stock?

Institutional investors own about 1.4% of Mentari Therapeutics's shares, spread across 20 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of MTRI.

Summary generated from market data by MetaCap's automated system. Methodology

Frequently asked questions

What percentage of Mentari Therapeutics is owned by institutions?

Institutions own about 1.4% of MTRI shares and 1.4% of the public float.

How much of Mentari Therapeutics do insiders own?

Insiders, such as officers and directors, own about 0.00% of MTRI shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related